Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BLLN

Billiontoone Inc

Nov 06 • 03:55PM ET

109.72

+49.72 82.87 %

Healthcare • Diagnostics & Research • USA • NASD

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	-	Perf Week	-
Market Cap	-	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	-
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	- -	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	- -	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	28.84	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	0.00%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	0.00%	Rel Volume	-	Prev Close	60.00
Employees	-	LT Debt/Eq	-	Earnings	-	SMA200	0.00%	Avg Volume	-	Price	109.72
IPO	Nov 06, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	1,306,340	Change	82.87%

Today 03:39PM	What Shutdown? The IPO Window Is Still Open for Some Companies (Barrons.com)
Nov-05-25 09:53PM	BillionToOne Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)

BillionToOne, Inc. develops DNA molecular counting technology. It can detect disorders such as sickle cell disease and cystic fibrosis. The company was founded by Oguzhan Atay, Sukrit Silas, and David Tsao and is headquartered in Palo Alto, CA.

open in yahoo | open in reuters | open in marketwatch | open in google

BLLN

Billiontoone Inc

Upgrade your FINVIZ experience